Human Psychopharmacology: Clinical and Experimental
Author Guidelines
Data Protection and Privacy
By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint Policy
Human Psychopharmacology: Clinical and Experimental will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
1. AIMS & SCOPE
Human Psychopharmacology: Clinical and Experimental (HUP) provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines. Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered. While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome. The following topics are of especial interest to the editors and readers of the Journal:
• All aspects of clinical psychopharmacology
• Efficacy and safety studies of novel and standard psychotropic drugs
• Studies of the adverse effects of psychotropic drugs
• Effects of psychotropic drugs on normal physiological processes
• Geriatric and paediatric psychopharmacology
• Ethical and psychosocial aspects of drug use and misuse
• Psychopharmacological aspects of sleep and chronobiology
• Neuroimaging and psychoactive drugs
• Phytopharmacology and psychoactive substances
• Drug treatment of neurological disorders
• Mechanisms of action of psychotropic drugs
• Ethnopsychopharmacology
• Pharmacogenetic aspects of mental illness and drug response
• Psychometrics: psychopharmacological methods and experimental design
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/10991077/homepage/forauthors.html
